Best of Hematology and Breast Cancer™ 2026, Nashville
(7.25 Credits)
Sheraton Grand Nashville Downtown
623 Union St, Nashville, TN, United States
February 6 - February 7, 2026
Conference Summary:
| Events Starts | Events Ends |
|---|---|
| February 6, 2026 | February 7, 2026 |
Organizing Committee:
Target Audience:
Learning Objectives:
Agenda
Day 1: Friday, February 6th, 2026
All timings are in Central Time (CDT, GMT-05:00) time.
02:30 PM - 03:30 PMRegistration, Networking, & Exhibits ( Ballroom Foyer & Ballroom 2/3 )
03:30 PM - 05:00 PMSession 1: Benign Hematology (Ballroom 4)
Session Chair:
Michelle Chi, MD
03:30 PM - 04:00 PM
Clotting Disorders
- Deva Sharma, MD
04:00 PM - 04:15 PM
Bleeding Disorders
- Michelle Chi, MD
04:15 PM - 04:45 PM
Updates in the management of Anemia
- Katherine Walsh, MD
04:45 PM - 05:00 PM
Updates in PNH / HUS / TTP
- Miriam Brown, DO
Day 2: Saturday, February 7th, 2026
07:00 AM - 08:00 AMRegistration, Exhibits & Breakfast ( Ballroom Foyer & Ballroom 2/3 )
08:00 AM - 08:05 AMWelcome (Ballroom 4)
08:05 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities
Conference Chair:
Justin Ryan Marquart, MBA
08:30 AM - 09:30 AMSession 2: AML/MDS ( Ballroom 4)
Session Chair:
Kateryna Fedorov, MD
08:30 AM - 09:00 AM
Menin inhibitors in acute Leukemias
- Kateryna Fedorov, MD
09:00 AM - 09:30 AM
MDS/MPN Updates 2025
- Ashwin Kishtagari, MD
09:30 AM - 10:45 AMSession 3: Multiple Myeloma ( Ballroom 4 )
Session Chair:
Muhamed Baljevic, MD
09:30 AM - 09:55 AM
Updates in TE and TIE NDMM
- Phyu Naing, MD
09:55 AM - 10:20 AM
Treatment approaches in early RRMM
- Noura Elsedawy, MD
10:20 AM - 10:45 AM
Treatment approaches in late RRMM
- Salyka Sengsayadeth, MD
10:45 AM - 11:00 AMBreak & Exhibits (Ballroom 2/3)
11:00 AM - 12:00 PMSession 4: Lymphoma ( Ballroom 4)
Session Chair:
Vivek Patel, MD
11:00 AM - 11:30 AM
Updates in the management of High-grade and large cell lymphomas
- Elisa De Togni, MD
11:30 AM - 12:00 PM
Updates in the management of indolent Lymphomas
- Vivek Patel, MD
12:00 PM - 01:00 PMLunch & Exhibits - Product Theater sponsored by Kura (non-CME accredited): Managing KOMZIFTI in Patients With R/R NPM1-m AML - Dr. James McCloskey ( Ryman Meeting Room)
01:00 PM - 02:20 PMSession 5: Metastatic Breast Cancer ( Ballroom 4)
Session Chair:
Erika Hamilton, MD
01:00 PM - 01:20 PM
Novel Backbones and Combinations in Metastatic HR+ Breast
- Sarah Premji, MD
01:20 PM - 01:40 PM
Debate: DB-09 vs. DB-03 for HER-2+ Breast
- Sonya Reid, MD
01:40 PM - 02:00 PM
Debate 2: DB-09 vs. DB-03 for HER-2+ Breast
- Gregory Vidal, MD, PhD
02:00 PM - 02:20 PM
Novel ADCs for metastatic HR+ and TNBC
- Erika Hamilton, MD
02:20 PM - 02:30 PMBreak & Exhibits ( Ballroom 4)
02:30 PM - 03:50 PMSession 6: Early Breast Cancer ( Ballroom 4)
Session Chair:
Kelsey Martin, ARNP
02:30 PM - 02:50 PM
Early HR+ Risk Estimation and Treatment
- Kelly Elizabeth McCann, MD, PhD
02:50 PM - 03:10 PM
Where do we stand with early TNBC?
- Sara Nunnery, MD
03:10 PM - 03:30 PM
Early HER-2+ Breast Cancer
- Samyukta Mullangi, MD, MBA
03:30 PM - 03:50 PM
Toxicity Challenges: ADCs and PIK3/mTOR/AKT
- Kelsey Martin, ARNP
03:50 PM - 03:55 PMAdjourn
Conference Chair
Muhamed Baljevic, MD
Vanderbilt University Medical Center
Erika Hamilton, MD
-
Session Chair
Kelsey Martin, ARNP
-
Vivek Patel, MD
Vanderbilt University Medical Center
Erika Hamilton, MD
-
Kateryna Fedorov, MD
-
Muhamed Baljevic, MD
Vanderbilt University Medical Center
Michelle Chi, MD
-
Faculty
Samyukta Mullangi, MD, MBA
-
Ashwin Kishtagari, MD
Vanderbilt University Medical Center
Gregory Vidal, MD, PhD
-
Sarah Premji, MD
Sarah Cannon Research Institute
Sara Nunnery, MD
-
Sonya Reid, MD
Vanderbilt
Katherine Walsh, MD
-
Kelly Elizabeth McCann, MD, PhD
University of California Los Angeles
Salyka Sengsayadeth, MD
Vanderbilt University Medical Center
Noura Elsedawy, MD
University of Tennessee Health Science Center
Deva Sharma, MD
-
Phyu Naing, MD
-
Miriam Brown, DO
-
Elisa De Togni, MD
-
Staff
Nafiso Bakar, n/a
Binaytara
Binay Shah, MBBS
-
Tara Shah, BSN
Binaytara
Audrey Kerby
-
Justin Ryan Marquart, MBA
Binaytara
Bhawana Srivastava, MBA
Binayatara
Acknowledgement of Commerical Support
This activity is supported with Independent Medical Education grants from:
- Gilead
- Stemline Therapeutics, Inc
Accreditation
Exhibit & Sponsorship Information
If you are interested in exhibiting at this meeting or if your company is already exhibiting and informed you of a discounted badge rate, please visit our Exhibit Page for those details.